-
Something wrong with this record ?
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study
M. Peiskerová, M. Kalousová, V. Danzig, B. Míková, M. Hodková, E. Němeček, A. Bani-Hani, D. Ambrož, H. Benáková, A. Linhart, T. Zima, V. Tesař,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
BioMedCentral
from 2000-12-01
BioMedCentral Open Access
from 2000
Directory of Open Access Journals
from 2000
Free Medical Journals
from 2000
PubMed Central
from 2000
Europe PubMed Central
from 2000 to 2020
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2000-10-01
Medline Complete (EBSCOhost)
from 2000-10-04
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
Springer Nature OA/Free Journals
from 2000-12-01
- MeSH
- Biomarkers blood MeSH
- Renal Insufficiency, Chronic blood ultrasonography MeSH
- Ventricular Dysfunction, Left blood ultrasonography MeSH
- Hypertrophy, Left Ventricular blood ultrasonography MeSH
- Middle Aged MeSH
- Humans MeSH
- Predictive Value of Tests MeSH
- Prospective Studies MeSH
- Aged MeSH
- Pregnancy Proteins blood MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the development of LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markers to echocardiographic parameters in CKD population. METHODS: We prospectively examined selected laboratory (PlGF, fibroblast growth factor-23 -FGF23, vitamin D, parathyroid hormone, extracellular newly identified RAGE-binding protein - EN-RAGE, B-type natriuretic peptide - BNP) and echocardiographic parameters in 62 patients with CKD 2-4. Mean follow-up was 36 ±10 months. Laboratory and echocardiographic data were collected 2-3 times, at the shortest interval of 12 months apart. Multivariate regression analysis was used to detect independent correlations of variables. RESULTS: Increased left ventricular mass index (LVMI, g/m2.7) was found in 29% patients with CKD 2-4, left ventricular (LV) diastolic dysfunction was detected in 74.1% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 30.6% patients). After 36 ± 10 months increased LVMI was found in 37.1% patients with CKD 2-4, LV diastolic dysfunction was detected in 75.8% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 32.3% patients). Following independent correlations were found: LVMI was related to PlGF, cholesterol, BNP, systolic blood pressure and serum creatinine. EN-RAGE correlated positively with left atrial diameter and inversely with E/A ratio. During the follow-up we found a significant increase in LVMI and left atrial diameter, whereas a significant decrease in LVEF was noted. CONCLUSION: According to our data, PlGF is independently related to increased LV mass in CKD, whereas EN-RAGE is more likely related to diastolic dysfunction in this population.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14050915
- 003
- CZ-PrNML
- 005
- 20140408114412.0
- 007
- ta
- 008
- 140401s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1471-2369-14-142 $2 doi
- 035 __
- $a (PubMed)23844967
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Peiskerová, Martina
- 245 10
- $a Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study / $c M. Peiskerová, M. Kalousová, V. Danzig, B. Míková, M. Hodková, E. Němeček, A. Bani-Hani, D. Ambrož, H. Benáková, A. Linhart, T. Zima, V. Tesař,
- 520 9_
- $a BACKGROUND: Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the development of LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markers to echocardiographic parameters in CKD population. METHODS: We prospectively examined selected laboratory (PlGF, fibroblast growth factor-23 -FGF23, vitamin D, parathyroid hormone, extracellular newly identified RAGE-binding protein - EN-RAGE, B-type natriuretic peptide - BNP) and echocardiographic parameters in 62 patients with CKD 2-4. Mean follow-up was 36 ±10 months. Laboratory and echocardiographic data were collected 2-3 times, at the shortest interval of 12 months apart. Multivariate regression analysis was used to detect independent correlations of variables. RESULTS: Increased left ventricular mass index (LVMI, g/m2.7) was found in 29% patients with CKD 2-4, left ventricular (LV) diastolic dysfunction was detected in 74.1% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 30.6% patients). After 36 ± 10 months increased LVMI was found in 37.1% patients with CKD 2-4, LV diastolic dysfunction was detected in 75.8% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 32.3% patients). Following independent correlations were found: LVMI was related to PlGF, cholesterol, BNP, systolic blood pressure and serum creatinine. EN-RAGE correlated positively with left atrial diameter and inversely with E/A ratio. During the follow-up we found a significant increase in LVMI and left atrial diameter, whereas a significant decrease in LVEF was noted. CONCLUSION: According to our data, PlGF is independently related to increased LV mass in CKD, whereas EN-RAGE is more likely related to diastolic dysfunction in this population.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertrofie levé komory srdeční $x krev $x ultrasonografie $7 D017379
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a těhotenské proteiny $x krev $7 D011257
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a chronická renální insuficience $x krev $x ultrasonografie $7 D051436
- 650 _2
- $a dysfunkce levé srdeční komory $x krev $x ultrasonografie $7 D018487
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kalousová, Marta $u -
- 700 1_
- $a Danzig, Vilem $u -
- 700 1_
- $a Míková, Blanka $u -
- 700 1_
- $a Hodková, Magdalena $u -
- 700 1_
- $a Němeček, Eduard $u -
- 700 1_
- $a Bani-Hani, Amjad $u -
- 700 1_
- $a Ambrož, David $u - $7 gn_A_00005417
- 700 1_
- $a Benáková, Hana $u -
- 700 1_
- $a Linhart, Ales $u -
- 700 1_
- $a Zima, Tomas $u -
- 700 1_
- $a Tesař, Vladimir $u -
- 773 0_
- $w MED00008194 $t BMC nephrology $x 1471-2369 $g Roč. 14, č. - (2013), s. 142
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23844967 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140408114459 $b ABA008
- 999 __
- $a ok $b bmc $g 1018051 $s 849495
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 14 $c - $d 142 $i 1471-2369 $m BMC nephrology $n BMC Nephrol $x MED00008194
- LZP __
- $a Pubmed-20140401